Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 438,336 |
|
|||||
| News | - | ||||||
| Day High | 5.24 | Low High |
|||||
| Day Low | 4.8601 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Ventyx Biosciences Inc | VTYX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0499 | -1.02% | 4.8601 | 12:36:14 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 5.05 | 4.8601 | 5.24 | 4.91 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,738 | 438,336 | US$ 5.08 | US$ 2,228,327 | - | 1.865 - 40.58 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 12:36:53 | 1 | US$ 4.8602 | USD |
Ventyx Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 290.34M | 59.25M | - | 0 | -192.96M | -3.26 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Ventyx Biosciences News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VTYX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.09 | 5.24 | 3.70 | 4.28 | 1,702,581 | 0.7701 | 18.83% |
| 1 Month | 4.94 | 5.24 | 3.70 | 4.48 | 1,093,535 | -0.0799 | -1.62% |
| 3 Months | 2.36 | 11.48 | 2.23 | 5.91 | 4,223,125 | 2.50 | 105.94% |
| 6 Months | 14.86 | 15.805 | 1.865 | 4.44 | 3,623,475 | -10.00 | -67.29% |
| 1 Year | 37.97 | 40.58 | 1.865 | 8.92 | 2,166,539 | -33.11 | -87.20% |
| 3 Years | 18.65 | 47.2508 | 1.865 | 14.25 | 1,128,192 | -13.79 | -73.94% |
| 5 Years | 18.65 | 47.2508 | 1.865 | 14.25 | 1,128,192 | -13.79 | -73.94% |
Ventyx Biosciences Description
| Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. Its lead product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors. |
